Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
Alpha Tau Medical Ltd. (Nasdaq: DRTS) and Tolmar International Ltd. have established a strategic collaboration to develop and commercialize Alpha DaRT®, a novel alpha-radiation therapy, targeting prostate cancer patients in the United States. Tolmar will invest $20M in equity at a premium and commit $15M to U.S. manufacturing capacity, securing exc…